Thrilling line-up of speakers for the 1st Edelris Symposium on Affinity Selection-Mass Spectrometry in Drug Discovery
June 2 & 3, 2021

If you need to accelerate the selection of high-quality hits for your biological targets,

If you are having difficulties identifying small-molecule ligands through other screening paradigms,

Register and listen to the Symposium’s leading speakers,

They will share their experiences so you can take full profit from this breakthrough screening technology.

More news

{"acf_fc_layout":"postList","postList_model":{"ID":3651,"post_author":"5","post_date":"2023-09-05 09:18:27","post_date_gmt":"2023-09-05 07:18:27","post_content":"","post_title":"More news","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"more-news","to_ping":"","pinged":"","post_modified":"2023-11-20 08:54:07","post_modified_gmt":"2023-11-20 07:54:07","post_content_filtered":"","post_parent":0,"guid":"https:\/\/www.edelris.com\/?post_type=waz_post_template&p=3651","menu_order":35,"post_type":"waz_post_template","post_mime_type":"","comment_count":"0","filter":"raw"},"postList_post_type":"actualites","postList_category_post":false,"postList_category_actualites":false,"postList_nb_item_per_line":"postList_2_item","postList_nb_max_item":"2","postList_order_by":"none","postList_order_date_which":"acf","postList_order_date_elements":"future","postList_order_date_ordering":"ASC","postList_set_link":true,"postList_link_waz_popup":true,"postList_category_navigation":false,"postList_rub_nav_dropdown":false,"postList_rub_nav_position":"left","postList_rub_nav_all":"Tous les articles","postList_pagination":false,"postList_pagination_nb_posts":12,"postList_pagination_btn_model":false,"postList_pagination_text":"","options":{"animation":false,"animation_delay":0,"animation_element_delay":100,"margin_bottom":"","postList_id":""},"postList_limit_title":"","postList_limit_subtitle":"","postList_limit_description":"","postList_limit_break":"word","postList_limit_add_to_end":"","postList_use_custom_post_type":false,"postList_custom_post_type":"","postList_custom_taxonomy":"","postList_custom_toxonomy_values":"","postList_custom_title":"","postList_custom_subtitle":"","postList_custom_description":"","postList_custom_date":""}

About Edelris

Our DNA

Edelris has continuously been bringing creative solutions to clients and partners from drug discovery organizations for the past 17 years, with a clear focus on Hit generation and Hit-to-Lead optimization. Edelris has pioneered the value of 3D, natural productlike compound collections for HTS and FBLD (Keymical Collections™ and Fragments), and offers successful medicinal chemistry and synthesis of explorative chemical libraries, encoded and non-encoded. Further to this, Edelris differentiates itself with EDEN (Edelris Discovery ENgine) based upon a 2 million proprietary compound collection (Keymical Space™) and AS-MS technologies.

More info at www.edelris.com and LinkedIn.